Oncology Drugs Market Research Report, Growth & Forecast

Publications found: 1,071
Sort by:

Global Breast Cancer Antibody Drug Conjugates Market Opportunity, Patent, Price, Approved Drug Sales & Clinical Trials Insight 2030

US$ 3,000.00

Research Methodology Global Breast Cancer Antibody Drug Conjugates Market Opportunity: > US$ 20 Billion By 2030Global & Regional Market Size Insight (Yearly & Quarterly): 2020 Till H1?2025Approved Br...

September 2025 330 pages

Global Lung Cancer Antibody Drug Conjugates Market Opportunity, Patent, Price & Clinical Trials Insight 2030

US$ 3,000.00

Finding & Highlights: Research MethodologyGlobal Lung Cancer Antibody Drug Conjugates Market Opportunity: > US$ 2 BillionGlobal & Regional Trends InsightCommercially Approved Lung Cancer Antibody Dru...

September 2025 250 pages

Middle East Gastric Cancer Diagnostics Market Size, Share & Trends Analysis Report By Product (Reagents & Consumables, Instruments), By Disease (Adenocarcinoma), By End Use (Diagnostic laboratories), By Country, And Segment Forecasts, 2025 - 2033

US$ 5,950.00

Market Size & Trends The Middle East gastric cancer diagnostics market size was estimated at USD 25.68 million in 2024 and is projected to reach USD 48.04 million by 2033, growing at a CAGR of 7.32% f...

August 2025 150 pages

Global Colorectal Cancer Drugs Market - 2024

US$ 2,999.00

The Global Colorectal Cancer Drugs Market was valued at US$ 12.60 billion in 2024 and is anticipated to reach by , at a CAGR of 0.052 from 2026 to 2032. The report delivers in-depth insights into key...

August 2025 207 pages

U.S. Liver Cancer Diagnostics Market Size, Share & Trends Analysis Report By Test Type (Laboratory Tests, Imaging, Endoscopy, Biopsy), By End-use (Hospitals & Diagnostic Laboratories, Pharmaceutical & CRO Laboratories), And Segment Forecasts, 2025 - 2033

US$ 5,950.00

U.S. Liver Cancer Diagnostics Market Trends The U.S. liver cancer diagnostics market size was estimated at USD 3.14 billion in 2024 and is projected to reach USD 4.44 billion by 2033, growing at a CAG...

August 2025 150 pages

Middle East Liver Cancer Diagnostics Market Size, Share & Trends Analysis Report By Test Type (Laboratory Tests, Imaging, Endoscopy, Biopsy), By End-Use, By Country, And Segment Forecasts, 2025 - 2033

US$ 5,950.00

Market Size & Trends The Middle East liver cancer diagnostics market size was estimated at USD 268.10 million in 2024 and is projected to reach USD 466.42 million by 2033, growing at a CAGR of 6.35% f...

August 2025 150 pages

Injectable Cytotoxic Drugs Market - 2023-2033

US$ 2,999.00

The Injectable Cytotoxic Drugs Market was valued at US$ 11.48 billion in 2023 and is anticipated to reach US$ 20.20 billion by 2033, at a CAGR of 0.059 from 2026 to 2032. The report delivers in-depth...

August 2025 243 pages

Middle East AI In Oncology Market Size, Share & Trends Analysis Report By Component (Software Solutions, Hardware), By Cancer Type (Breast Cancer, Lung Cancer), By Application, By End-use, By Country, And Segment Forecasts, 2025 - 2033

US$ 4,950.00

Middle East AI in Oncology Market Trends The Middle East AI in oncology market size was estimated at USD 111.33 million in 2024 and is projected to grow at a CAGR of 21.94% from 2025 to 2033. The risi...

August 2025 100 pages

Pancreatic Cancer Market - 2022

US$ 2,999.00

The Pancreatic Cancer Market was valued at US$ 2.5 billion in 2022 and is anticipated to reach by , at a CAGR of 0.111 from 2026 to 2032. The report delivers in-depth insights into key market dynamics...

August 2025 200 pages

U.S. Oncology Based Molecular Diagnostics Market Size, Share & Trends Analysis Report By Type (Breast Cancer, Lung Cancer), By Product (Instruments, Reagents), By Technology (PCR, Sequencing), By Region, And Segment Forecasts, 2025 - 2033

US$ 5,950.00

Market Size & Trends The U.S. oncology based molecular diagnostics market size was estimated at USD 1.49 billion in 2024 and is expected to grow at a CAGR of 5.2% from 2025 to 2033. Key market driving...

August 2025 136 pages

Global PD-L1 Testing and Therapeutics Market - 2023-2033

US$ 2,999.00

The Global PD-L1 Testing and Therapeutics Market was valued at US$ 52.05 billion in 2023 and is anticipated to reach US$ 159.84 billion by 2033, at a CAGR of 0.116 from 2026 to 2032. The report delive...

August 2025 219 pages

Global Basal Cell Carcinoma Treatment Market 2026

US$ 2,999.00

The Global Basal Cell Carcinoma Treatment Market was valued at in and is anticipated to reach by , at a CAGR of 0.094 from 2026 to 2032. The report delivers in-depth insights into key market dynamics,...

August 2025 218 pages

Hadron Therapy Market Forecasts to 2032 – Global Analysis By Type of Particle (Proton Therapy, Carbon Ion Therapy and Other Ion Therapy), Component (Equipment, Software and Services), Cancer Type, End User, and By Geography

US$ 4,150.00

According to Stratistics MRC, the Global Hadron Therapy Market is accounted for $2.1 billion in 2025 and is expected to reach $5.3 billion by 2032 growing at a CAGR of 13.6% during the forecast period...

August 2025 200 pages

Asia Pacific Oncology Based Molecular Diagnostics Market Size, Share & Trends Analysis Report By Type (Breast Cancer, Lung Cancer), By Product (Instruments, Reagents), By Technology (PCR, Sequencing), By Region, And Segment Forecasts, 2025 - 2033

US$ 5,950.00

Market Size & Trends The Asia Pacific oncology based molecular diagnostics market size was estimated at USD 822.5 million in 2024 and is projected to reach USD 1,560.75 million by 2033, growing at a C...

August 2025 136 pages

Tumor Ablation Market - 2022

US$ 2,999.00

The Tumor Ablation Market was valued at US$ 797.4 million in 2022 and is anticipated to reach by , at a CAGR of 0.131 from 2026 to 2032. The report delivers in-depth insights into key market dynamics,...

August 2025 217 pages

Cancer Supportive Care Drugs Market Outlook 2025-2034: Market Share, and Growth Analysis By Product Type (Chemotherapy-Induced Nausea and Vomiting (CINV) Management, Pain Management, Psychological Support, Nutritional Support), By Application, By End User, By Technology

US$ 3,950.00

The Cancer Supportive Care Drugs Market size is valued at USD 18.9 billion in 2025 and is projected to reach USD 27.4 billion by 2033, registering a compound annual growth rate (CAGR) of 4.77% over th...

August 2025 150 pages

Chemotherapy Market Outlook 2025-2034: Market Share, and Growth Analysis By Product Type (Cytotoxic Drugs, Targeted Therapy, Immunotherapy), By Application, By End User, By Technology

US$ 3,950.00

The Chemotherapy Market size is valued at USD 34.4 billion in 2025 and is projected to reach USD 74.7 billion by 2033, registering a compound annual growth rate (CAGR) of 10.2% over the forecast perio...

August 2025 150 pages

Global Cancer Antibody Drug Conjugates Market Opportunity, Patent, Price, Approved Drug Sales & Clinical Trials Insight 2031

US$ 4,200.00

Findings & Highlights: Global Cancer Antibody Drug Conjugates Market Opportunity: > USD 70 Billion By 2031Global & Regional Market Size Insight (Yearly & Quarterly): 2020 Till H1’2025 Global Cancer A...

August 2025 1300 pages

Glioblastoma Multiforme Treatment Market Report by Drug Type (Temozolomide, Bevacizumab, Carmustine, Radiosensitizers, and Others), Route of Administration (Oral, Parenteral), Type of Molecule (Small Molecule, Biologics), Distribution Channel (Hospitals, Pharmacies, and Others), and Region 2025-2033

US$ 3,999.00

The global glioblastoma multiforme treatment market size reached USD 2.3 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 4.1 Billion by 2033, exhibiting a growth rate (CA...

August 2025 138 pages

Multiple Myeloma Drugs Market Size, Share, Trends and Forecast by Therapy, Drug Type, End User, Distribution Channel, and Region, 2025-2033

US$ 3,999.00

The global multiple myeloma drugs market size was valued at USD 23.46 Billion in 2024. Looking forward, IMARC Group estimates the market to reach USD 36.86 Billion by 2033, exhibiting a CAGR of 4.89%...

August 2025 121 pages

Oncology Based Molecular Diagnostics Market Size, Share & Trends Analysis Report By Type (Breast Cancer, Lung Cancer), By Product (Instruments, Reagents), By Technology (PCR, Sequencing), By Region, And Segment Forecasts, 2025 - 2033

US$ 5,950.00

This report can be delivered to the clients within 3 Business Days Oncology Based Molecular Diagnostics Market The global oncology based molecular diagnostics market size was estimated at USD 3.75 b...

July 2025 136 pages

Liquid Biopsy For Early Cancer Detection And Monitoring Market Size, Share & Trends Analysis Report By Biomarker (Circulating Tumor DNA (ctDNA), Circulating Tumor Cells (CTCs)), By Technology, By Cancer, By End Use, By Region, And Segment Forecasts, 2025 - 2033

US$ 5,950.00

This report can be delivered to the clients within 3 Business Days Liquid Biopsy For Early Cancer Detection And Monitoring Market The global liquid biopsy for early cancer detection and monitoring m...

July 2025 136 pages

Prostate Cancer Biomarkers Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025 - 2034

US$ 4,850.00

The Global Prostate Cancer Biomarkers Market was valued at USD 4.7 billion in 2024 and is estimated to grow at a CAGR of 13.5% to reach USD 16.5 billion by 2034. The market growth is propelled by the...

July 2025 132 pages

U.S. Prostate Cancer Biomarkers Market Size, Share & Trends Analysis Report By Type (Protein Biomarkers, Metabolomic Biomarkers), By Application (Screening & Early Detection, Companion Diagnostics), By End-use, And Segment Forecasts, 2025 - 2033

US$ 5,950.00

This report can be delivered to the clients within 3 Business Days Market Size & Trends The U.S. prostate cancer biomarkers market size was estimated at USD 1.7 billion in 2024 and is expected to gr...

July 2025 120 pages

Non-Small Cell Lung Cancer Therapeutics Market - 2024-2033

US$ 2,999.00

The Non-Small Cell Lung Cancer Therapeutics Market was valued at US$ 21.33 billion in 2024 and is anticipated to reach US$ 64.92 billion by 2033, at a CAGR of 0.117 from 2026 to 2032. The report deliv...

July 2025 207 pages

Esophageal Cancer Treatment Market - 2024-2033

US$ 2,999.00

The Esophageal Cancer Treatment Market was valued at US$ 1.31 billion in 2024 and is anticipated to reach US$ 2.66 billion by 2033, at a CAGR of 0.082 from 2026 to 2032. The report delivers in-depth i...

July 2025 218 pages

Oncology Based In-vivo CRO Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, By Indication (Blood Cancer, Solid Tumor), By Model (Syngeneic Model, Patient Derived Xenograft, Xenograft), By Region & Competition, 2020-2030F

US$ 4,500.00

Market Overview The Global Oncology Based In-vivo CRO Market was valued at USD 1.24 billion in 2024 and is projected to grow at a CAGR of 8.29% through 2030. This dynamic sector plays a critical role...

July 2025 180 pages

United States Herceptin Market By Product (Biologic, Biosimilar), By Application (Breast Cancer, Stomach/Gastric Cancer, Others), By Distribution Channel (Hospital Pharmacy, Specialty Pharmacy, Others), By Region, Competition, Forecast & Opportunities, 2020-2030F

US$ 3,500.00

Market Overview The United States Herceptin Market was valued at USD 1.32 billion in 2024 and is projected to reach USD 1.74 billion by 2030, growing at a CAGR of 4.66%. The market is advancing steadi...

July 2025 82 pages

Colorectal Cancer (CRC) – Pipeline Insights – 2018 Size, Share, Industry, Forecast and outlook (2024-2031) 2026

US$ 2,999.00

The Colorectal Cancer (CRC) – Pipeline Insights – 2018 Size, Share, Industry, Forecast and outlook (2024-2031) was valued at in and is anticipated to reach by , at a CAGR of xx% from 2026 to 2032. The...

July 2025 218 pages

IDO Inhibitors – Pipeline Insights – 2018 Size, Share, Industry, Forecast and outlook (2024-2031) 2026

US$ 2,999.00

The IDO Inhibitors – Pipeline Insights – 2018 Size, Share, Industry, Forecast and outlook (2024-2031) was valued at in and is anticipated to reach by , at a CAGR of xx% from 2026 to 2032. The report d...

July 2025 218 pages

Kidney Cancer – Pipeline Insights – 2018 Size, Share, Industry, Forecast and outlook (2024-2031) 2026

US$ 2,999.00

The Kidney Cancer – Pipeline Insights – 2018 Size, Share, Industry, Forecast and outlook (2024-2031) was valued at in and is anticipated to reach by , at a CAGR of xx% from 2026 to 2032. The report de...

July 2025 207 pages

Hemato Oncology Testing Market Size, Share & Trends Analysis Report By Product (Assay Kits & Reagents, Services), By Cancer (Leukemia, Lymphoma), By Technology, By End-use, By Region, And Segment Forecasts, 2025 - 2030

US$ 5,950.00

This report can be delivered to the clients within 3 Business Days Hemato Oncology Testing Market The global hemato oncology testing market size was estimated at USD 3.60 billion in 2024 and is proj...

July 2025 120 pages

Erleada Market Size, Share & Trends Analysis Report By Type (Branded, Generic), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies), By Region, And Segment Forecasts, 2025 - 2033

US$ 5,950.00

This report can be delivered to the clients within 2 Business Days Erleada Market The global erleada market size was estimated at USD 2,999 million in 2024 and is projected to reach USD 6,166 millio...

July 2025 150 pages

U.S. Erleada Market Size, Share & Trends Analysis Report By Type (Branded, Generic), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies), And Segment Forecasts, Key Companies, And Competitive Analysis, 2025 - 2033

US$ 5,950.00

This report can be delivered to the clients within 3 Business Days Market Size & Trends The U.S. erleada market size was estimated at USD 1.28 billion in 2024 and is projected to reach USD 2.5 billi...

July 2025 120 pages

Cancer Pain Market - 2023-2033

US$ 2,999.00

The Cancer Pain Market was valued at US$ 7.45 Billion in 2023 and is anticipated to reach US$ 12.45 Billion by 2033, at a CAGR of 0.059 from 2026 to 2032. The report delivers in-depth insights into ke...

July 2025 223 pages

Silent Cancer Therapeutics Market - 2023-2033

US$ 2,999.00

The Silent Cancer Therapeutics Market was valued at US$ 13.50 Billion in 2023 and is anticipated to reach US$ 30.48 Billion by 2033, at a CAGR of 0.087 from 2026 to 2032. The report delivers in-depth...

July 2025 200 pages

Head and Neck Cancer Pipeline Insights 2025 2026

US$ 2,999.00

The Head and Neck Cancer Pipeline Insights 2025 was valued at in and is anticipated to reach by , at a CAGR of xx% from 2026 to 2032. The report delivers in-depth insights into key market dynamics, in...

July 2025 223 pages

Interventional Oncology Devices Market - 2024-2033

US$ 2,999.00

The Interventional Oncology Devices Market was valued at US$ 2.70 Billion in 2024 and is anticipated to reach US$ 5.00 Billion by 2033, at a CAGR of 0.071 from 2026 to 2032. The report delivers in-dep...

July 2025 217 pages

Clinical Oncology Next Generation Sequencing Market Size, Share & Trends Analysis Report By Workflow (NGS Pre-Sequencing, NGS Sequencing, NGS Data Analysis), By Technology, By Application, By End Use, By Region, And Segment Forecasts, 2025 - 2033

US$ 5,950.00

This report can be delivered to the clients within 2 Business Days Clinical Oncology Next Generation Sequencing Market The global clinical oncology next generation sequencing market size was estimat...

July 2025 125 pages

Circulating Tumor Cells Market Size, Share, and Analysis, By Technology (Immunomagnetic Enrichment, Microfluidics, Dielectrophoresis, Others), By Application (Cancer Detection, Drug Development, Research, Prognostics), By End-User (Hospitals, Research Institutes, Pharma Companies, Biotech Firms), By Region … Forecast 2025–2035

US$ 4,950.00

From 2025 to 2035, the Circulating Tumor Cells Market is expected to register a CAGR of 8.8%. Adoption accelerates as stakeholders seek higher performance, lower lifecycle costs, and compliance with t...

July 2025 656 pages

Global Selective Estrogen Receptor Degrader (SERDs) Market Opportunity, Generic Availability, Drug Dosage, Price & Clinical Trials Insight 2030

US$ 2,800.00

Please note: extra shipping charges are applied when purchasing Hard Copy License depending on the location. Global Selective Estrogen Receptor Degrader (SERDs) Market Opportunity, Generic Availabil...

July 2025 110 pages

Hepatocellular Carcinoma Treatment Market - 2024-2033

US$ 2,999.00

The Hepatocellular Carcinoma Treatment Market was valued at US$ 995.63 million in 2024 and is anticipated to reach US$ 1,964.88 million by 2033, at a CAGR of 0.074 from 2026 to 2032. The report delive...

June 2025 243 pages

Filters

Search

Publishers

28
6
25
231
87
69
3
123
237
1
4
22
56
3
3
19
2
4
107
41

Regions

1
4
3
2
3
2
1
2
10
1,043

Price

Date

Pages

Offers